GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lifecore Biomedical Inc (NAS:LFCR) » Definitions » Cyclically Adjusted PB Ratio

Lifecore Biomedical (Lifecore Biomedical) Cyclically Adjusted PB Ratio : 0.66 (As of Jun. 04, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Lifecore Biomedical Cyclically Adjusted PB Ratio?

As of today (2024-06-04), Lifecore Biomedical's current share price is $5.72. Lifecore Biomedical's Cyclically Adjusted Book per Share for the quarter that ended in May. 2023 was $8.70. Lifecore Biomedical's Cyclically Adjusted PB Ratio for today is 0.66.

The historical rank and industry rank for Lifecore Biomedical's Cyclically Adjusted PB Ratio or its related term are showing as below:

LFCR's Cyclically Adjusted PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.875
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lifecore Biomedical's adjusted book value per share data for the three months ended in May. 2023 was $-0.143. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $8.70 for the trailing ten years ended in May. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Lifecore Biomedical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Lifecore Biomedical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecore Biomedical Cyclically Adjusted PB Ratio Chart

Lifecore Biomedical Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.29 1.34 1.41 1.05 0.94

Lifecore Biomedical Quarterly Data
Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 1.16 0.95 0.66 0.94

Competitive Comparison of Lifecore Biomedical's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecore Biomedical's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Cyclically Adjusted PB Ratio falls into.



Lifecore Biomedical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Lifecore Biomedical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=5.72/8.7
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecore Biomedical's Cyclically Adjusted Book per Share for the quarter that ended in May. 2023 is calculated as:

For example, Lifecore Biomedical's adjusted Book Value per Share data for the three months ended in May. 2023 was:

Adj_Book=Book Value per Share/CPI of May. 2023 (Change)*Current CPI (May. 2023)
=-0.143/128.3144*128.3144
=-0.143

Current CPI (May. 2023) = 128.3144.

Lifecore Biomedical Quarterly Data

Book Value per Share CPI Adj_Book
201308 6.937 98.675 9.021
201311 7.079 98.334 9.237
201402 7.394 99.057 9.578
201405 7.573 100.373 9.681
201408 7.665 100.352 9.801
201411 7.796 99.635 10.040
201502 7.951 99.032 10.302
201505 8.093 100.333 10.350
201508 8.229 100.548 10.501
201511 8.329 100.135 10.673
201602 7.575 100.040 9.716
201605 7.762 101.355 9.827
201608 7.903 101.617 9.979
201611 7.998 101.829 10.078
201702 8.153 102.779 10.179
201705 8.241 103.256 10.241
201708 8.346 103.587 10.338
201711 8.396 104.072 10.352
201802 9.023 105.052 11.021
201805 9.117 106.148 11.021
201808 9.131 106.383 11.013
201811 9.126 106.338 11.012
201902 9.311 106.649 11.203
201905 9.282 108.048 11.023
201908 9.090 108.245 10.775
201911 8.884 108.519 10.505
202002 8.487 109.139 9.978
202005 7.906 108.175 9.378
202008 7.563 109.662 8.849
202011 7.125 109.793 8.327
202102 6.978 110.968 8.069
202105 6.913 113.576 7.810
202108 6.580 115.421 7.315
202111 5.298 117.269 5.797
202202 4.887 119.703 5.239
202205 2.976 123.323 3.096
202208 3.274 124.958 3.362
202211 2.448 125.607 2.501
202302 1.128 126.928 1.140
202305 -0.143 128.314 -0.143

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lifecore Biomedical  (NAS:LFCR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Lifecore Biomedical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecore Biomedical (Lifecore Biomedical) Business Description

Traded in Other Exchanges
N/A
Address
3515 Lyman Boulevard, Chaska, MN, USA, 55318
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid.
Executives
Raymond T. White director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Holdings, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. Ii director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. I director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Asset Management, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Christopher S Kiper director 12121 WILSHIRE BLVD, SUITE 1240, LOS ANGELES CA 90025
Nathaniel Calloway director C/O ANEBULO PHARMACEUTICALS, INC., 1415 RANCH ROAD 620 SOUTH, SUITE 201, LAKEWAY TX 78734
Wynnefield Partners Small Cap Value Lp I 10 percent owner 450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123
Raymond H Diradoorian director C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Joshua Schechter director C/O THE PANTRY, INC., 305 GREGSON DRIVE, CARY NC 27511
Patrick D Walsh director 14282 FRANKLIN AVE., TUSTIN CA 92780
John D Morberg officer: Chief Financial Officer C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Albert D. Bolles director CONAGRA FOODS, INC., ONE CONAGRA DRIVE, MS 1-330, OMAHA NE 68102
James G Hall officer: Executive Vice President 3515 LYMAN BLVD., CHASKA MN 55318

Lifecore Biomedical (Lifecore Biomedical) Headlines